Form 4: ReposiTrak CEO Randall Fields Sells Over $150K in Company Stock Under Pre-Arranged Charitable Plan

ReposiTrak, Inc. CEO Randall K. Fields reported the sale of 7,500 shares of common stock over three days in mid-June 2025, totaling approximately $152,310, executed under a Rule 10b5-1 trading plan for charitable commitments.

Summary

• Randall K. Fields, who serves as Chief Executive Officer, Director, and a 10% Owner of ReposiTrak, Inc. (TRAK), reported the sale of 7,500 shares of the company's common stock.
• The sales were conducted over three consecutive days: 1,500 shares on June 16, 2025; 3,500 shares on June 17, 2025; and 2,500 shares on June 18, 2025.
• The shares were sold at weighted average prices of $20.5329 on June 16, 2025, $20.1592 on June 17, 2025, and $20.3816 on June 18, 2025.
• The total approximate value of the shares sold across these transactions is $152,310.55.
• These transactions were executed automatically pursuant to a pre-arranged Rule 10b5-1 trading plan.
• The trading plan was adopted by Mr. Fields in his capacity as Trustee of the 2022 RK Fields Charitable Remainder Unitrust, which is the managing member of RK Fields Charitable 2022, LLC.
• The stated purpose of establishing the trading plan was to enable Mr. Fields to meet some of his charitable commitments.
• Following these transactions, Mr. Fields' direct beneficial ownership of common stock stands at 3,683,955 shares, with additional indirect ownership through various entities and his spouse.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While insider selling can sometimes be viewed negatively, the fact that it's under a pre-arranged 10b5-1 plan for charitable purposes mitigates concerns about opportunistic selling. It's a routine personal financial management activity for an executive.

Positives

• The sales were conducted under a pre-arranged Rule 10b5-1 trading plan, indicating a planned and transparent divestment rather than an immediate reaction to new, non-public information.
• The stated purpose of the sales is to fulfill charitable commitments, which can be viewed positively as a philanthropic endeavor by the CEO.

Negatives

• Insider selling, even under a 10b5-1 plan, can sometimes be perceived negatively by some investors as it reduces the insider's direct stake in the company.

Risks

• No specific operational or financial risks for ReposiTrak, Inc. are mentioned in this Form 4 filing. The primary 'risk' is the potential for negative investor perception regarding insider selling, although this is mitigated by the pre-arranged 10b5-1 plan and charitable purpose.

Future Outlook

The document does not contain any forward-looking statements or guidance regarding ReposiTrak, Inc.'s future performance, strategic direction, or financial outlook. It solely reports insider trading activity.

Management Comments

• "The reported sale occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in his capacity as Trustee of the 2022 RK Fields Charitable Remainder Unitrust, the managing member of RK Fields Charitable 2022, LLC."
• "The Trading Plan was established to enable the Reporting Person to meet some of his charitable commitments."
• "The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4) to this Form 4."

Industry Context

This Form 4 filing reports a routine insider stock transaction under a pre-arranged plan. It does not provide information that allows for an analysis of broader industry trends, competitive positioning, or market dynamics relevant to ReposiTrak, Inc.'s industry.

Comparison to Industry Standards

• This document is a standard SEC Form 4 filing reporting insider transactions and does not contain information that allows for a comparison of ReposiTrak's operational or financial results against global benchmarks or specific comparable companies/projects.
• The execution of stock sales by an executive under a Rule 10b5-1 plan for personal financial management or philanthropic purposes is a common and accepted practice within corporate governance standards.

Related Party Transactions

• The sales were conducted by RK Fields Charitable 2022, LLC, an entity managed by the Reporting Person as Trustee of the 2022 RK Fields Charitable Remainder Unitrust, which constitutes a related party transaction.
• Indirect beneficial ownership is also reported through Riverview Financial Corp., Fields Management, Inc., and the spouse of the reporting person, indicating other related entities.

Stakeholder Impact

• Shareholders: The sale of shares by a key executive could be perceived as a slight negative, but the pre-arranged nature and charitable purpose mitigate significant concern. It represents a minor reduction in the CEO's overall beneficial ownership relative to his total holdings.
• Employees, Customers, Suppliers, Creditors: The transaction is unlikely to have any direct impact on these stakeholders as it relates to personal stock management by an executive, not operational or financial changes within the company.

Next Steps

• The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the reported ranges.

Key Dates

Recommendation

Keywords

ReposiTrak, TRAK, Randall K. Fields, SEC Form 4, Insider Trading, Stock Sale, 10b5-1 Plan, CEO, Director, 10% Owner, Charitable Commitments, Equity Transaction